RASSF1 and cancer: In conclusion, genetic mutation in the Kras gene and epigenetic modification in RASSF1A, FHIT and MGMT genes in sporadic CRC are associated with the overall development of the disease and may be used as diagnostic or prognostic markers in this group of cancers.